---  
layout: startup_page  
title: "Ouro Medicines"  
id: "ouromedicines.com"  
permalink: "/ouromedicinesouromedicines.com01102025/"  
website: "https://www.ouromedicines.com/"  
funding_round: "Series A"  
funding_amount: "$120M"  
investors: "TPG Life Sciences Innovations, NEA, Norwest Venture Partners, Monograph Capital, GSK, UPMC Enterprises, Boyu/Zoo Capital, LongRiver Investments"  
about: "Ouro Medicines is a biotechnology company developing immune reset therapeutics for chronic immune-mediated diseases. Their approach uses T cell engagers to target and deplete specific pathogenic cell populations, aiming to reset the immune system and create durable remissions without ongoing immunosuppression. Their lead product candidate, OM336, is a BCMA-directed bispecific T cell engager currently in a Phase 2 expansion study in China."  
markets: "Biotechnology, Healthtech, Immunotherapy, Medical"  
hq: "San Francisco, California, United States"  
founded_year: "2024"  
linkedin: "https://www.linkedin.com/company/ouromedicines"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/ouro-medicines"  
pitchbook: ""  

date_display: "10-Jan-2025"  
date: "2025-01-10"

# SEO Optimization  
meta_title: "Ouro Medicines - Series A Funding ($120M)"  
meta_description: "Ouro Medicines, Ouro Medicines is a biotechnology company developing immune reset therapeutics for chronic immune-mediated diseases. Their approach uses T cell engage..."  
meta_keywords: "Ouro Medicines, Biotechnology, Healthtech, Immunotherapy, Medical, Series A funding"  
canonical_url: "https://startup.projectstartups.com/ouromedicinesouromedicines.com01102025/"  
---